Cardiovascular Systems Inc (NASDAQ:CSII) Sellers Strengthened By 2.8% Their Shorts

April 16, 2018 - By Richard Doty

Big Money Sentiment increased to 1.02 in Q4 2017. It has change of 0.23, from 2017Q3’s 0.79. The ratio is positive due to Cardiovascular Systems, Inc. positioning: 17 sold and 41 reduced. 14 funds bought stakes and 45 increased stakes. Investors holded 24.82 million in 2017Q3 but now own 26.16 million shares or 5.38% more.
First Foundation Advsrs holds 16,175 shs. Clarivest Asset Mgmt Limited Liability Corporation invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Weiss Multi invested 0.02% of its capital in Cardiovascular Systems, Inc. (NASDAQ:CSII). Panagora Asset Mgmt accumulated 0% or 46,761 shs. Hbk Invests Limited Partnership has 93,600 shs. 132,167 were accumulated by Numeric Investors Ltd Liability Com. Barclays Pcl, United Kingdom-based fund reported 12,263 shs. Royal National Bank Of Canada reported 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Thrivent For Lutherans invested in 153,116 shs or 0.01% of the stock. Ameritas Invest Prns owns 2,803 shs. Legal & General Grp Public Limited Liability has 8,182 shs. Manufacturers Life Ins Company The has 25,888 shs. Gru stated it has 0% of its capital in Cardiovascular Systems, Inc. (NASDAQ:CSII). Comml Bank Of Ny Mellon has invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Nuveen Asset Mgmt Lc reported 0.01% in Cardiovascular Systems, Inc. (NASDAQ:CSII).

Cardiovascular Systems Inc (NASDAQ:CSII) recorded an increase of 2.8% in short interest. It was announced in April by FINRA the 1.04M short interest on CSII. The up change of 2.8% from 1.01M shares was reported. With Average volume 265,200, CSII’s former position will take 4 days to restore. 3.15% is Cardiovascular Systems Inc float short.

CSII reached $22.67 on during the last trading session after $0.22 change.Currently Cardiovascular Systems, Inc. is downtrending after 21.67% change in last April 16, 2017. CSII has also 102,994 shares volume. CSII underperformed by 33.22% the S&P 500.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States.The firm is valued at $753.06 million. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.Last it reported negative earnings. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Ratings Coverage

In total 3 analysts cover Cardiovascular Systems (NASDAQ:CSII). “Buy” rating has 1, “Sell” are 0, while 2 are “Hold”. 33% are bullish. 3 are the (NASDAQ:CSII)’s analyst reports since December 15, 2017 according to StockzIntelligence Inc. On Thursday, February 8 the firm has “Outperform” rating given by Leerink Swann. The stock rating was initiated by William Blair with “Hold” on Thursday, December 21. The stock rating was downgraded by Needham to “Hold” on Friday, December 15.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.